Personalized Therapeutic Anti-tumor Vaccine With Pembrolizumab and Standard of Care Chemotherapy in Squamous Non-Small Cell Lung Cancer and Extensive Stage Small Cell Lung Cancer

Clinical trial NCT03166254 · WITHDRAWN

Trial details

NCT number: NCT03166254
Sponsor: Washington University School of Medicine
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer NSCLC Non-small Cell Lung Cancer Small Cell Lung Extensive Stage

Start date: 2019-04-30
Primary completion: 2022-06-30
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.